Gynecologic Oncology · 2016 · 17 citations · 24 references
MedicineOncologyPharmacoeconomicsChemotherapyGynecologic OncologyPrecision MedicineChemotherapy PharmacogenomicsDrug Resistance GenomicsMalignant NeoplasmsOvarian CancerPersonalized Cancer TherapyTherapeutic ResistanceCost-utility Analysis InputsOvarian Cancer ChemotherapyOvarian Cancer TreatmentPersonalized Cancer TreatmentPlatinum SensitivityPlatinum-based RegimensTherapeutic Drug ResistanceTherapeutic Resistance Genomics
24
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Integrated genomic analyses of ovarian carcinoma
Debra Bell, Andrew Berchuck, Narciso Olvera et al. · Nature · 2011 · 8.2K citations · Full text
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa et al. · New England Journal of Medicine · 2013 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +15
First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer
Benjamin Solomon, Tony Mok, Dong‐Wan Kim et al. · New England Journal of Medicine · 2014 · 3.2K citations · Full text
Medicine, Oncology, Pharmacology +12